Recent advances in paclitaxel biosynthesis and regulation

Area of Science:

• Plant biochemistry
• Genomics
• Cancer therapeutics

Background:

• Paclitaxel (PTX) is a vital anti-cancer drug derived from yew species.
• Demand for PTX is increasing due to new cancer treatment applications.
• Understanding PTX biosynthesis is crucial for ensuring a stable supply of this essential medicine.

Purpose of the Study:

• To review recent advances in Paclitaxel (PTX) biosynthesis and regulation.
• To highlight the impact of transcriptomic and genomic data on understanding PTX production.
• To explore strategies for improving PTX production, including heterologous expression and epigenetic manipulation.

Main Methods:

• Review of recent scientific literature on PTX biosynthesis and regulation.
• Analysis of transcriptomic data from Taxus species.
• Examination of genomic sequencing and annotation of Taxus genomes.
• Discussion of epigenetic regulation mechanisms in plant cell cultures.

Main Results:

• Elucidation of two functional gene sets for PTX biosynthesis.
• Identification of new potential for producing PTX in heterologous hosts.
• Enhanced understanding of the regulation of PTX biosynthesis, including epigenetic factors.
• Development of potential tools to manipulate epigenetic regulation for improved PTX production.

Conclusions:

• Advances in genomics and transcriptomics have significantly improved our understanding of PTX biosynthesis.
• The identified gene sets and regulatory insights offer new strategies for PTX production.
• Targeting epigenetic regulation presents a promising approach to overcome challenges in long-term cell cultures and enhance PTX yield.